Stemina Biomarker Discovery, Inc.

Madison,  WI 
United States
  • Booth: 1818

Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development and commercialization of molecular biomarkers to improve drug safety and human health. Stemina’s cell-based assays arise from the strategic convergence human embryonic stem (hES) cells and metabolomics. Stemina uses mass spectrometry to analyze the small molecules secreted by hES cells, differentiated cells made from hES cells, iPS cells, and cancer stem cells in response to drugs, injury or disease.


Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".